Beck Bode LLC’s Labcorp LH Stock Holding History

Beck Bode LLC’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,048	Closed	-$212K	–	165
2022 Q4	$212K	Sell	1,048 -2,549	-71%	-$498K	0.05%	142
2022 Q3	$633K	Sell	3,597 -23	-0.6%	-$4.71K	0.14%	121
2022 Q2	$729K	Buy	3,620 +594	+20%	+$127K	0.16%	109
2022 Q1	$686K	Buy	+3,026	New	+$712K	0.15%	89

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Beck Bode LLC's LH Position: Q1 2023 in Review

Beck Bode LLC sold out of Labcorp (LH) in Q1 2023, closing a stake of 1,048 shares — an estimated $212K sold.

Beck Bode LLC first reported a position in LH in Q1 2022 and held it in 4 quarters. The position peaked at $729K in Q2 2022. 940 funds tracked by Wall St. Rank hold LH as of Q1 2023.

Beck Bode LLC reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
Beck Bode LLC sold 1,048 Labcorp shares in Q1 2023, an estimated $212K.
Beck Bode LLC first reported a position in Labcorp in Q1 2022 and held it in 4 quarters.
Beck Bode LLC's Labcorp position peaked at $729K in Q2 2022.
940 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on Beck Bode LLC's 13F filing for Q1 2023, filed 3 May 2023.